The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular characterization of appendiceal goblet cell carcinoid.
 
Hiroyuki Arai
No Relationships to Disclose
 
Yasmine Baca
No Relationships to Disclose
 
Curtis Johnston
No Relationships to Disclose
 
Richard M. Goldberg
Honoraria - Amgen; Amgen; Amgen; Amgen
Consulting or Advisory Role - Merck; Merck; Merck; Merck; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA; Novartis; Novartis; Novartis; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Merck; Merck; Merck; Merck; Merck KGaA; Merck KGaA; Merck KGaA; Merck KGaA
 
Philip Agop Philip
Honoraria - Amgen; Amgen; Amgen; Amgen; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; ASLAN Pharmaceuticals; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Biologics; Biologics; Biologics; Biologics; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Blueprint Medicines; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Caris MPI; Caris MPI; Caris MPI; Caris MPI; Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Lexi Pharma; Lexi Pharma; Lexi Pharma; Lexi Pharma; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Sanofi; Sanofi; Sanofi; Sanofi; SynCoreBio; SynCoreBio; SynCoreBio; SynCoreBio; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck; Merrimack; Merrimack; Merrimack; Merrimack; novartis; novartis; novartis; novartis; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences; TriSalus Life Sciences
Speakers' Bureau - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Celgene; Celgene; Celgene; Celgene; Ipsen; Ipsen; Ipsen; Ipsen; Merck; Merck; Merck; Merck
Research Funding - Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); Advanced Accelerator Applications (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); ASLAN Pharmaceuticals (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Caris Life Sciences (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); halozyme (Inst); halozyme (Inst); halozyme (Inst); halozyme (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); incyte (Inst); incyte (Inst); incyte (Inst); incyte (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); Momenta Pharmaceuticals (Inst); novartis (Inst); novartis (Inst); novartis (Inst); novartis (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); Plexxikon (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); QED Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); tyme (Inst); tyme (Inst); tyme (Inst); TYME (Inst); TYME (Inst); TYME (Inst); TYME (Inst); tyme (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; celgene; celgene; celgene; celgene; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals
 
Andreas Seeber
No Relationships to Disclose
 
Francesca Battaglin
Travel, Accommodations, Expenses - Amgen; Amgen; Amgen; Amgen; Bayer; Bayer; Bayer; Bayer
 
Joanne Xiu
No Relationships to Disclose
 
Jingyuan Wang
No Relationships to Disclose
 
Shivani Soni
No Relationships to Disclose
 
Wu Zhang
No Relationships to Disclose
 
Jimmy J. Hwang
No Relationships to Disclose
 
Anthony Frank Shields
Consulting or Advisory Role - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; ImaginAb; ImaginAb; ImaginAb; ImaginAb; TransTarget; TransTarget; TransTarget; TransTarget
Speakers' Bureau - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences
Research Funding - Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Daiichi Sankyo; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; H3 Biomedicine; Halozyme; Halozyme; Halozyme; Halozyme; ImaginAb; ImaginAb; ImaginAb; ImaginAb; Incyte; Incyte; Incyte; Incyte; Inovio Pharmaceuticals; Inovio Pharmaceuticals; Inovio Pharmaceuticals; Inovio Pharmaceuticals; Lexicon; Lexicon; Lexicon; Lexicon; LSK BioPharma; LSK BioPharma; LSK BioPharma; LSK BioPharma; Plexxikon; Plexxikon; Plexxikon; Plexxikon; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Torque; Torque; Torque; Torque; Xencor; Xencor; Xencor; Xencor
Travel, Accommodations, Expenses - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; GE Healthcare; GE Healthcare; GE Healthcare; GE Healthcare; ImaginAb; ImaginAb; ImaginAb; ImaginAb; Inovio Pharmaceuticals; Inovio Pharmaceuticals; Inovio Pharmaceuticals; Inovio Pharmaceuticals; TransTarget; TransTarget; TransTarget; TransTarget
 
John Marshall
Employment - Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences
Honoraria - Amgen; Amgen; Amgen; Amgen; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Celgene; Celgene; Celgene; Celgene; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Amgen; Amgen; Amgen; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Caris Life Sciences; Celgene; Celgene; Celgene; Celgene; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Speakers' Bureau - Amgen; Amgen; Amgen; Amgen; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Bayer/Onyx; Celgene; Celgene; Celgene; Celgene; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst); Pfizer (Inst)
 
W. Michael Korn
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Bayer; Bayer; Bayer; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Isofol Medical; Isofol Medical; Isofol Medical; Isofol Medical; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Merck Serono; Merck Serono; Merck Serono; Merck Serono; Roche; Roche; Roche; Roche
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Merck Serono; Merck Serono; Merck Serono; Merck Serono